GNRH1 and spontaneous abortion: Overall, NMA data suggest that combinatorial treatments, with the addition of SCGNRH-a on a VP base results in improved clinical pregnancy and live birth events and reduced miscarriage events in participants undergoing OS either a standard GnRH antagonist or agonist protocol.